Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Post-Doctoral Fellowship, Gene Therapy Center, University of North Carolina at Chapel Hill 2005 - 2009
  • Ph.D., The Hebrew University of Jerusalem (Israel) 2005
  • M.Sc., The Hebrew University of Jerusalem (Israel) 1998
  • Ph.D., Grodno State Medical University (Republic of Belarus) 1995
• 

  Duke Appointment History

  • Assistant Research Professor in the Department of Neurobiology, Neurobiology, Basic Science Departments 2016 - 2019
• Research
• 

  Selected Grants

  • Production of Adeno-Associated Vectors (AAVs) for Kallyope 2019 - 2021
  • Production of lentiviral vectors (LVs) 2018 - 2019
  • Production of Adeno-Associated Vectors (AAVs) 2018
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Tagliafierro, Lidia, Ekaterina Ilich, Malik Moncalvo, Jeffrey Gu, Ahila Sriskanda, Carole Grenier, Susan K. Murphy, Ornit Chiba-Falek, and Boris Kantor. “Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models..” J Vis Exp, no. 145 (March 29, 2019). https://doi.org/10.3791/59241.
       Full Text  Link to Item
    • Kantor, Boris, Lidia Tagliafierro, Jeffrey Gu, Madison E. Zamora, Ekaterina Ilich, Carole Grenier, Zhiqing Y. Huang, Susan Murphy, and Ornit Chiba-Falek. “Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD..” Mol Ther 26, no. 11 (November 7, 2018): 2638–49. https://doi.org/10.1016/j.ymthe.2018.08.019.
       Full Text  Link to Item
    • Vijayraghavan, Sriram, and Boris Kantor. “A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells..” J Vis Exp, no. 130 (December 12, 2017). https://doi.org/10.3791/56915.
       Full Text  Open Access Copy  Link to Item
    • Ortinski, Pavel I., Bernadette O’Donovan, Xiaoyu Dong, and Boris Kantor. “Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing..” Mol Ther Methods Clin Dev 5 (June 16, 2017): 153–64. https://doi.org/10.1016/j.omtm.2017.04.002.
       Full Text  Open Access Copy  Link to Item
• Teaching & Mentoring
• 

  Recent Courses

  • NEUROBIO 393: Research Independent Study 2019
  • NEUROSCI 494: Research Independent Study 2 2019

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.